Koninklijke Philips N.V. provided sales guidance for the year 2022. For the full year, the company target to deliver 5%-6% comparable sales growth excluding Sleep & Respiratory Care. For the Group, the company target 3%-5% comparable sales growth and a 40-90 basis-points improvement in Adjusted EBITA margin.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.6 EUR | +2.59% | +2.30% | -7.04% |
Apr. 23 | PHILIPS NV : Jefferies reiterates its Sell rating | ZD |
Apr. 18 | PHILIPS NV : Receives a Sell rating from Jefferies | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.04% | 18.43B | |
+8.35% | 209B | |
+9.41% | 175B | |
+11.75% | 131B | |
+19.34% | 99.98B | |
-0.84% | 61.12B | |
+15.08% | 52.34B | |
-2.10% | 46.5B | |
+0.10% | 39.24B | |
+11.50% | 38.47B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Koninklijke Philips N.V. Provides Sales Guidance for the Year 2022